Envíos recientes

Mostrando ítems 1511-1515 de 11841

Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia

2021- Mosquera Orgueira, Adrián; Peleteiro Raindo, Andrés; Cid López, Miguel; Antelo Rodríguez, Beatriz; Díaz Arias, José; [et al.]
Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients

2018- Hernández-Boluda, J.C.; Pereira, A.; Pastor-Galán, I.; Alvarez-Larrán, A.; Savchuk, A.; [et al.]
Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience

2022- Labrador, J.; Saiz-Rodríguez, M.; de Miguel, D.; de Laiglesia, A.; Rodríguez-Medina, C.; [et al.]
Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors

2023- Pérez-Lamas, L.; Luna, A.; Boque, C.; Xicoy, B.; Giraldo, P.; [et al.]
Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study

2019- Barbui, T.; Ghirardi, A.; Masciulli, A.; Carobbio, A.; Palandri, F.; [et al.]